Royce & Associates LP reduced its stake in Exponent, Inc. (NASDAQ:EXPO) by 8.1% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 260,030 shares of the business services provider’s stock after selling 22,800 shares during the period. Royce & Associates LP owned 0.98% of Exponent worth $15,160,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of EXPO. State of Alaska Department of Revenue raised its position in Exponent by 0.7% in the first quarter. State of Alaska Department of Revenue now owns 2,830 shares of the business services provider’s stock valued at $168,000 after buying an additional 20 shares during the period. Alps Advisors Inc. raised its position in Exponent by 0.3% in the second quarter. Alps Advisors Inc. now owns 8,206 shares of the business services provider’s stock valued at $478,000 after buying an additional 21 shares during the period. Bank of Montreal Can raised its position in Exponent by 0.7% in the second quarter. Bank of Montreal Can now owns 3,231 shares of the business services provider’s stock valued at $189,000 after buying an additional 22 shares during the period. Miles Capital Inc. raised its position in Exponent by 1.8% in the first quarter. Miles Capital Inc. now owns 3,824 shares of the business services provider’s stock valued at $228,000 after buying an additional 67 shares during the period. Finally, UBS Group AG raised its position in Exponent by 0.3% in the first quarter. UBS Group AG now owns 36,673 shares of the business services provider’s stock valued at $2,184,000 after buying an additional 98 shares during the period. 88.26% of the stock is owned by hedge funds and other institutional investors.

Shares of Exponent, Inc. (EXPO) opened at 66.30 on Thursday. The company has a market capitalization of $1.71 billion, a price-to-earnings ratio of 34.37 and a beta of 0.62. The company has a 50-day moving average price of $63.79 and a 200-day moving average price of $60.39. Exponent, Inc. has a 12 month low of $48.42 and a 12 month high of $68.30.

Exponent (NASDAQ:EXPO) last released its quarterly earnings data on Tuesday, July 18th. The business services provider reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.41 by $0.10. The company had revenue of $84.10 million during the quarter, compared to analysts’ expectations of $79.30 million. Exponent had a net margin of 15.94% and a return on equity of 16.52%. The firm’s quarterly revenue was up 14.7% on a year-over-year basis. During the same period in the previous year, the company earned $0.38 EPS. On average, equities analysts anticipate that Exponent, Inc. will post $1.97 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 22nd. Shareholders of record on Friday, September 1st will be given a $0.21 dividend. The ex-dividend date of this dividend is Wednesday, August 30th. This represents a $0.84 annualized dividend and a yield of 1.27%. Exponent’s dividend payout ratio (DPR) is 43.52%.

ILLEGAL ACTIVITY WARNING: This report was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The original version of this report can be read at https://www.thecerbatgem.com/2017/08/31/exponent-inc-expo-shares-sold-by-royce-associates-lp.html.

Several research firms have recently weighed in on EXPO. Zacks Investment Research raised Exponent from a “hold” rating to a “buy” rating and set a $74.00 price objective for the company in a research report on Thursday, July 20th. Cantor Fitzgerald reissued a “buy” rating and issued a $75.00 price objective (up from $69.00) on shares of Exponent in a research report on Wednesday, July 19th. ValuEngine raised Exponent from a “sell” rating to a “hold” rating in a research report on Thursday, July 20th. Finally, BidaskClub raised Exponent from a “strong sell” rating to a “sell” rating in a research report on Wednesday, July 5th.

In other Exponent news, insider Sally Shepard sold 1,255 shares of the business’s stock in a transaction dated Friday, July 21st. The shares were sold at an average price of $65.37, for a total value of $82,039.35. Following the completion of the sale, the insider now directly owns 1,560 shares of the company’s stock, valued at approximately $101,977.20. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Harri Kytomaa sold 12,000 shares of the business’s stock in a transaction dated Friday, August 4th. The shares were sold at an average price of $66.38, for a total transaction of $796,560.00. Following the completion of the sale, the insider now directly owns 11,360 shares of the company’s stock, valued at $754,076.80. The disclosure for this sale can be found here. Over the last three months, insiders sold 51,855 shares of company stock valued at $3,392,502. 2.80% of the stock is owned by corporate insiders.

Exponent Company Profile

Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO).

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Stock Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related stocks with our FREE daily email newsletter.